Clinical Roundup Vitamin D may play a role in prostate cancer disparities, Cedars-Sinai researchers find April 21, 2023Vol.49 No.16
Clinical Roundup Basket trial results suggest advanced FGFR-altered solid tumors may benefit from FGFR inhibitor pemigatinib April 21, 2023Vol.49 No.16
Clinical Roundup Combination PARP and ATR inhibitors show positive early results April 21, 2023Vol.49 No.16
Clinical Roundup Phase I MD Anderson study shows YAP/TEAD inhibitor VT3989 is well tolerated and shows antitumor activity in advanced mesothelioma and NF2-mutant cancers April 21, 2023Vol.49 No.16
Clinical Roundup Phase I trial of novel allogeneic CAR T-cell therapy shows positive early results in metastatic ccRCC April 21, 2023Vol.49 No.16
Clinical Roundup Benefit of chemotherapy for early-stage breast cancer varies by tumor anatomy, Roswell Park study shows April 21, 2023Vol.49 No.16
Clinical Roundup MD Anderson research: combination therapies for BRAF V600E mutations, cancer biomarkers in extracellular vesicles, and strategies for overcoming treatment resistance in lung cancer and AML April 21, 2023Vol.49 No.16
Clinical Roundup New CAR T strategy highly effective against small cell lung cancer in preclinical study April 21, 2023Vol.49 No.16
Clinical Roundup Wilmot Cancer Institute researchers discover how to steer army of immune cells toward cancer April 21, 2023Vol.49 No.16
Clinical Roundup Keytruda + Cabometyx shows clinical benefit for head and neck squamous cell carcinoma in phase II trial April 14, 2023Vol.49 No.15
